Interleukin-22 ameliorates liver fibrogenesis by attenuating hepatic stellate cell activation and downregulating the levels of inflammatory cytokines

World Journal of Gastroenterology

Volumn 21, Issue 5, 2015, Pages 1531-1545

  Lu, Dong Hong ^a   Guo, Xiao Yun ^a   Qin, Shan Yu ^a   Luo, Wei ^a   Huang, Xiao Li ^a   Chen, Mei ^a   Wang, Jia Xu ^a   Ma, Shi Jia ^a   Yang, Xian Wen ^a   Jiang, Hai Xing ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Hepatic fibrosis; Interleukin 22; T helper 1 cells; T helper 17 cells; T helper 22 cells

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; AROMATIC HYDROCARBON RECEPTOR; BETA ACTIN; CARBON TETRACHLORIDE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 6; MESSENGER RNA; OLIVE OIL; RECOMBINANT CYTOKINE; RECOMBINANT INTERLEUKIN 22; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; AUTACOID; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROGENESIS; FLOW CYTOMETRY; HELPER CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; LIVER HISTOLOGY; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; STELLATE CELL; TH1 CELL; TH17 CELL; TH22 CELL; TREATMENT DURATION; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; GENETICS; IMMUNOLOGY; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; METABOLISM; PATHOLOGY; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; TIME FACTOR;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CARBON TETRACHLORIDE; CYTOKINES; HEPATIC STELLATE CELLS; INFLAMMATION MEDIATORS; INTERLEUKINS; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; TH1 CELLS; TH17 CELLS; TIME FACTORS;

EID: 84922569926     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i5.1531     Document Type: Article

References (41)

1. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008; 134: 1655-1669 [PMID: 18471545 DOI: 10.1053/j.gastro.2008.03.003]
2. + T cell responses following splenectomy in hepatitis C virus-related liver cirrhosis. Clin Exp Immunol 2011; 165: 243-250 [PMID: 21615390 DOI: 10.1111/j.1365-2249.2011.04393.x]
3. Heymann F, Hammerich L, Storch D, Bartneck M, Huss S, Rüsseler V, Gassler N, Lira SA, Luedde T, Trautwein C, Tacke F. Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C-C motif chemokine receptor 8 in mice. Hepatology 2012; 55: 898-909 [PMID: 22031018 DOI: 10.1002/hep.24764]
4. Karlmark KR, Wasmuth HE, Trautwein C, Tacke F. Chemokinedirected immune cell infiltration in acute and chronic liver disease. Expert Rev Gastroenterol Hepatol 2008; 2: 233-242 [PMID: 19072358 DOI: 10.1586/17474124.2.2.233]
5. Littman DR, Rudensky AY. Th17 and regulatory T cells in mediating and restraining inflammation. Cell 2010; 140: 845-858 [PMID: 20303875 DOI: 10.1016/j.cell.2010.02.021]
6. Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009; 361: 888-898 [PMID: 19710487 DOI: 10.1056/NEJMra0707449]
7. Baroni GS, D'Ambrosio L, Curto P, Casini A, Mancini R, Jezequel AM, Benedetti A. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology 1996; 23: 1189-1199 [PMID: 8621153]
8. Zhang JY, Song CH, Shi F, Zhang Z, Fu JL, Wang FS. Decreased ratio of Treg cells to Th17 cells correlates with HBV DNA suppression in chronic hepatitis B patients undergoing entecavir treatment. PLoS One 2010; 5: e13869 [PMID: 21079784 DOI: 10.1371/journal.pone.0013869]
9. Niu Y, Liu H, Yin D, Yi R, Chen T, Xue H, Zhang S, Lin S, Zhao Y. The balance between intrahepatic IL-17(+) T cells and Foxp3(+) regulatory T cells plays an important role in HBV-related end-stage liver disease. BMC Immunol 2011; 12: 47 [PMID: 21851644 DOI: 10.1186/1471-2172-12-47]
10. Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 2009; 10: 857-863 [PMID: 19578369 DOI: 10.1038/ni.1767]
11. Trifari S, Kaplan CD, Tran EH, Crellin NK, Spits H. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol 2009; 10: 864-871 [PMID: 19578368 DOI: 10.1038/ni.1770]
12. Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Karow M, Flavell RA. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 2007; 27: 647-659 [PMID: 17919941]
13. Radaeva S, Sun R, Pan HN, Hong F, Gao B. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 2004; 39: 1332-1342 [PMID: 15122762]
14. Ren X, Hu B, Colletti LM. IL-22 is involved in liver regeneration after hepatectomy. Am J Physiol Gastrointest Liver Physiol 2010; 298: G74-G80 [PMID: 19875704 DOI: 10.1152/ajpgi.00075.2009]
15. Yang L, Zhang Y, Wang L, Fan F, Zhu L, Li Z, Ruan X, Huang H, Wang Z, Huang Z, Huang Y, Yan X, Chen Y. Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22. J Hepatol 2010; 53: 339-347 [PMID: 20452699 DOI: 10.1016/j.jhep.2010.03.004]
16. Kong X, Feng D, Wang H, Hong F, Bertola A, Wang FS, Gao B. Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice. Hepatology 2012; 56: 1150-1159 [PMID: 22473749 DOI: 10.1002/hep.25744]
17. Holt AP, Salmon M, Buckley CD, Adams DH. Immune interactions in hepatic fibrosis. Clin Liver Dis 2008; 12: 861-882, x [PMID: 18984471 DOI: 10.1016/j.cld.2008.07.002]
18. Weng HL, Feng DC, Radaeva S, Kong XN, Wang L, Liu Y, Li Q, Shen H, Gao YP, Müllenbach R, Munker S, Huang T, Chen JL, Zimmer V, Lammert F, Mertens PR, Cai WM, Dooley S, Gao B. IFN-9 inhibits liver progenitor cell proliferation in HBV-infected patients and in 3,5-diethoxycarbonyl-1,4-dihydrocollidine dietfed mice. J Hepatol 2013; 59: 738-745 [PMID: 23747755 DOI: 10.1016/j.jhep.2013.05.041]
19. Gao B, Waisman A. Th17 cells regulate liver fibrosis by targeting multiple cell types: many birds with one stone. Gastroenterology 2012; 143: 536-539 [PMID: 22842060 DOI: 10.1053/j.gastro.2012.07.031]
20. Shi Z, Wakil AE, Rockey DC. Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc Natl Acad Sci USA 1997; 94: 10663-10668 [PMID: 9380692]
21. Tu CT, Li J, Wang FP, Li L, Wang JY, Jiang W. Glycyrrhizin regulates CD4+T cell response during liver fibrogenesis via JNK, ERK and PI3K/AKT pathway. Int Immunopharmacol 2012; 14: 410-421 [PMID: 22940540 DOI: 10.1016/j.intimp.2012.08.013]
22. Bot A. Immunoglobulin deficient mice generated by gene targeting as models for studying the immune response. Int Rev Immunol 1996; 13: 327-340 [PMID: 8884429]
23. Sun HQ, Zhang JY, Zhang H, Zou ZS, Wang FS, Jia JH. Increased Th17 cells contribute to disease progression in patients with HBVassociated liver cirrhosis. J Viral Hepat 2012; 19: 396-403 [PMID: 22571901 DOI: 10.1111/j.1365-2893.2011.01561.x]
24. Ge J, Wang K, Meng QH, Qi ZX, Meng FL, Fan YC. Implication of Th17 and Th1 cells in patients with chronic active hepatitis B. J Clin Immunol 2010; 30: 60-67 [PMID: 19756987 DOI: 10.1007/s10875-009-9328-2]
25. - cells into stable T regulatory cells in patients with autoimmune hepatitis. Gastroenterology 2012; 142: 1526-1535.e6 [PMID: 22387392 DOI: 10.1053/j.gastro.2012.02.041]
26. Lemmers A, Moreno C, Gustot T, Maréchal R, Degré D, Demetter P, de Nadai P, Geerts A, Quertinmont E, Vercruysse V, Le Moine O, Devière J. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 2009; 49: 646-657 [PMID: 19177575 DOI: 10.1002/hep.22680]
27. Sun XF, Gu L, Deng WS, Xu Q. Impaired balance of T helper 17/T regulatory cells in carbon tetrachloride-induced liver fibrosis in mice. World J Gastroenterol 2014; 20: 2062-2070 [PMID: 24616573 DOI: 10.3748/wjg.v20.i8.2062]
28. Meng F, Wang K, Aoyama T, Grivennikov SI, Paik Y, Scholten D, Cong M, Iwaisako K, Liu X, Zhang M, Osterreicher CH, Stickel F, Ley K, Brenner DA, Kisseleva T. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology 2012; 143: 765-776.e1-e3 [PMID: 22687286 DOI: 10.1053/j.gastro.2012.05.049]
29. Tan Z, Qian X, Jiang R, Liu Q, Wang Y, Chen C, Wang X, Ryffel B, Sun B. IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation. J Immunol 2013; 191: 1835-1844 [PMID: 23842754 DOI: 10.4049/jimmunol.1203013]
30. Hara M, Kono H, Furuya S, Hirayama K, Tsuchiya M, Fujii H. Interleukin-17A plays a pivotal role in cholestatic liver fibrosis in mice. J Surg Res 2013; 183: 574-582 [PMID: 23578751 DOI: 10.1016/j.jss.2013.03.025]
31. Mastelic B, do Rosario AP, Veldhoen M, Renauld JC, Jarra W, Sponaas AM, Roetynck S, Stockinger B, Langhorne J. IL-22 Protects Against Liver Pathology and Lethality of an Experimental Blood-Stage Malaria Infection. Front Immunol 2012; 3: 85 [PMID: 22566965 DOI: 10.3389/fimmu.2012.00085]
32. Chestovich PJ, Uchida Y, Chang W, Ajalat M, Lassman C, Sabat R, Busuttil RW, Kupiec-Weglinski JW. Interleukin-22: implications for liver ischemia-reperfusion injury. Transplantation 2012; 93: 485-492 [PMID: 22262131 DOI: 10.1097/TP.0b013e3182449136]
33. Xing WW, Zou MJ, Liu S, Xu T, Gao J, Wang JX, Xu DG. Hepatoprotective effects of IL-22 on fulminant hepatic failure induced by d-galactosamine and lipopolysaccharide in mice. Cytokine 2011; 56: 174-179 [PMID: 21843953 DOI: 10.1016/j.cyto.2011.07.022]
34. Ki SH, Park O, Zheng M, Morales-Ibanez O, Kolls JK, Bataller R, Gao B. Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3. Hepatology 2010; 52: 1291-1300 [PMID: 20842630 DOI: 10.1002/hep.23837]
35. Park O, Wang H, Weng H, Feigenbaum L, Li H, Yin S, Ki SH, Yoo SH, Dooley S, Wang FS, Young HA, Gao B. In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression. Hepatology 2011; 54: 252-261 [PMID: 21465510 DOI: 10.1002/hep.24339]
36. Kong Q, Wu W, Yang F, Liu Y, Xue Y, Gao M, Lai W, Pan X, Yan Y, Pang Y, Deng Y. Increased expressions of IL-22 and Th22 cells in the coxsackievirus B3-Induced mice acute viral myocarditis. Virol J 2012; 9: 232 [PMID: 23050732 DOI: 10.1186/1743-422X-9-232]
37. Ben-Sasson SZ, Hu-Li J, Quiel J, Cauchetaux S, Ratner M, Shapira I, Dinarello CA, Paul WE. IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation. Proc Natl Acad Sci USA 2009; 106: 7119-7124 [PMID: 19359475 DOI: 10.1073/pnas.0902745106]
38. Chung Y, Chang SH, Martinez GJ, Yang XO, Nurieva R, Kang HS, Ma L, Watowich SS, Jetten AM, Tian Q, Dong C. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 2009; 30: 576-587 [PMID: 19362022 DOI: 10.1016/j.immuni.2009.02.007]
39. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006; 24: 179-189 [PMID: 16473830]
40. Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, Levy DE, Leonard WJ, Littman DR. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007; 8: 967-974 [PMID: 17581537]
41. Iwamoto S, Iwai S, Tsujiyama K, Kurahashi C, Takeshita K, Naoe M, Masunaga A, Ogawa Y, Oguchi K, Miyazaki A. TNF-alpha drives human CD14+ monocytes to differentiate into CD70+ dendritic cells evoking Th1 and Th17 responses. J Immunol 2007; 179: 1449-1457 [PMID: 17641010]